Clinical Trials Logo

Clinical Trial Summary

This study will assess the impact of FTIRS typing on the spread of ESBL-E in intensive care units


Clinical Trial Description

Multidrug resistant enterobacterales (MDR-E) are a major threat for patients hospitalized in intensive care units (ICUs). To prevent MDR-E spread in ICUs, rectal swabs are routinely performed and cultured on selective media. However, bacterial identification and antimicrobial susceptibility results are not sufficient to diagnose cross transmissions. The gold standard technique is based on genomic analysis that require whole genome sequencing (WGS) of bacteria and followed by multilocus sequence typing (MLST) and Single Nucleotide Polymorphism (SNP) typing. This technology is rather expensive and not applicable in all centers. Fourier Transform InfraRed Spectroscopy (FTIRS) is a developing method for rapid bacterial typing. This technology is simple and results can be obtained in one hour. It is therefore adapted to continuous surveillance of MDR-E. In France, extended spectrum betalactamase producing enterobacteriaceae (ESBL-E) represent the vast majority of MDR-E. We postulate that early diagnosis of cross-transmission by FTIRS may prevent the spread of ESBL-E in ICUs and favor compliance with hygiene measures. The aim of this study will be to assess the impact of systematic FTIRS typing of ESBL-E on ESBL-E cross-transmissions in ICUs. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05872152
Study type Interventional
Source University Hospital, Caen
Contact Camille Jeanne-Leroyer
Phone +33(0)231065947
Email jeanneleroyer-c@chu-caen.fr
Status Not yet recruiting
Phase N/A
Start date September 1, 2023
Completion date September 1, 2025

See also
  Status Clinical Trial Phase
Completed NCT02520440 - INtestinal Failure, multiPle Organ Failure ANd CItrulline Assessment N/A
Recruiting NCT04695119 - Sepsis in the ICU-II
Not yet recruiting NCT04502511 - Heterogeneity of Critical Illness: a Cohort Study
Recruiting NCT03825250 - The Val-CARD Trial Phase 1/Phase 2
Completed NCT03344627 - Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients N/A
Completed NCT04772703 - DNA Damage in Critically Ill COVID-19 Patients
Recruiting NCT04015973 - The PRE-OP ENERGY Trial N/A
Withdrawn NCT03933930 - Comparing the Prognosis of Lactate-directed and Goal-directed Therapy in Hyperthermic Intraperitoneal Chemotherapy. N/A
Completed NCT03075605 - PROOF: Pancreatitis-associated Risk Of Organ Failure
Not yet recruiting NCT06330610 - Evaluation of the Efficiency of Intermittent Enteral Nutrition on Multi-organ Failure From Patients With Mechanical Ventilation in Intensive Care Unit N/A
Not yet recruiting NCT03282253 - Elevated Stearoyl-CoA Desaturase-1 Expression Predicts the Disease Severity of Severe Acute Pancreatitis N/A
Completed NCT05972980 - Ventilator-Associated Pneumonia in Critically Ill COVID-19 vs. Non-COVID-19 Patients
Withdrawn NCT03167788 - Red Cell Rejuvenation for the Attenuation of Transfusion Associated Organ Injury in Cardiac Surgery Phase 2
Recruiting NCT05405426 - Trial of Indication-Based Transfusion of Red Blood Cells in ECMO N/A
Completed NCT04732481 - Evaluation of Corrected Carotid Flow Time Variations During Passive Leg Lift to Predict Response to Filling.